All News

Three targeted drugs have recently been approved to treat diffuse large B-cell lymphoma, broadening the treatment options for patients with this aggressive blood cancer, according to Dr. Germame Ajebo.

This benefit observed with Venclexta (venetoclax) plus Rituxan (rituximab) for patients with CLL was particularly strong in patients with undetectable minimal residual disease, which may predict clinical outcome after chemoimmunotherapy.

The RACE for Children Act will create more clinical trial options for young patients with cancer and, ultimately, more pediatric oncology drugs.

One recently approved drug and two experimental treatments offer the promise of a wider range of options for patients with follicular lymphoma, according to Dr. Germame Ajebo.

Exercise may help prevent cancer or its recurrence and improve quality of life for survivors of the disease.

Treatment with a novel immuno-oncology therapy demonstrated a manageable safety profile with preliminary efficacy in patients with metastatic castration-resistant prostate cancer.

Cancer loves glucose, which is why fasting, restricting calorie consumption or following the ketogenic diet may make chemotherapy and some other cancer treatments more effective and easier to tolerate, early evidence shows.

A two-time cancer survivor looks back at her cancer journey and offers 4 tips for a first-time patient with cancer.

Taking cholesterol-lowering drugs may provide a mortality benefit in women with newly diagnosed colorectal cancer, breast cancer and melanoma, although more research is needed to confirm this potential association.

From Nov. 1-Dec. 15, consumers can shop for health plans offered under the Affordable Care Act. One advocate suggests that all patients compare policies to ensure the best fit for their particular needs and budget.

Results of this trial led to an accelerated FDA approval of Opdivo (nivolumab) and Yervoy (ipilimumab) in March to treat this specific patient population.

On social media, CURE® recently asked its readers to give a shout out to their ‘cancer hero’: the person or persons who they met while on their cancer journey and they now admire.

In the midst of the COVID-19 pandemic, one personalized mask helped this cancer survivor forge ahead through the challenges of quarantine, and the challenges ahead.

Each month, we take a look back at the most popular CURE® stories. Here are the top five for October 2020.

One patient shares their story of how her oncology nurse changed her cancer journey by being there with her every step of the way.

When we talk about cancer with our loved ones, we can forget the different experiences shared and leave our issues unresolved. But that doesn’t mean it’s time to stop communicating.

Oncology nurses not only give to their patients without reservations, but they also help their other nurses without reservations.

Oncology nurses have a special understanding of their patients and their patients' needs. One patient shares their story on how that special understanding made a major difference in her cancer journey.

Twelve works will be selected to appear in a 2021 CURE® calendar, and all submissions will be displayed in the magazine’s online art gallery.

A breast surgical oncologist at The University of Texas MD Anderson Cancer Center notes that while breast cancer screening can be delayed a few months, it should not be skipped altogether.

2020 has been a challenging year, especially for survivors and those with cancer, but you can look forward to the new year. You just have to imagine the possibilities.

Two sisters diagnosed with the same stage of breast cancer in the same spot three weeks apart take part in proton therapy trial, Mayo Clinic and Google Health partner to investigate the use of artificial intelligence in assisting with radiotherapy treatments and more from the weekly roundup of news and research happening in the cancer landscape.

Ultra-precise drug targeting brings new hope for patients with non-small cell lung cancer that harbors rare mutations.

Giving fewer courses of chemotherapy and no radiation could become a new standard for patients with stage 1 or 2 diffuse large B cell lymphoma based on the results of a recent study.

Here is a list of some recent trials that launched within the cancer space in October.

Using the full use of my left hand for a few months, I relied more on my lymphedema limb. Those with lymphedema, I learned, might do well to avoid fractures as best they can.

As colorectal cancer is becoming more prevalent in younger patients, the U.S. Preventive Services Task Force (USPSTF) introduced a draft recommendation that, if accepted, will lower the screening age from 50 years to 45 years in those with average risk.

5-year follow up data from a promising trial shows survival benefits with the combination treatment of Tafinlar and Mekinist with patients with melanoma.

A study assessing the value of movement found that it improved physical and mental health in older adults who had survived cancer, as well as those with no history of the disease.

As a caregiver for a patient with cancer, it can be an isolating experience. However, being around other caregivers can be a painful reminder of the sacrifices made along the cancer journey.